Investors

Date	Name	Title	Type	Shares Traded	Price Range
Sep 18, 2012	powchik peter	Officer	Option Execute	15,000	16.80
Sep 18, 2012	powchik peter	Officer	Automatic Sell	7,823	148.78
Aug 1, 2012	powchik peter	Officer	Option Execute	14,990	15.64 - 21.92
Jul 26, 2012	powchik peter	Officer	Automatic Sell	7,019	130.40 - 131.07
Jul 25, 2012	powchik peter	Officer	Option Execute	15,000	16.80
Jul 25, 2012	powchik peter	Officer	Automatic Sell	7,981	126.76
Feb 22, 2012	powchik peter	Officer	Automatic Sell	49,254	94.71 - 98.05
Feb 21, 2012	powchik peter	Officer	Option Execute	109,866	15.64 - 21.92
Feb 21, 2012	powchik peter	Officer	Automatic Sell	60,612	100.32
Aug 1, 2011	powchik peter	Officer	Option Execute	15,144	15.64
Jul 26, 2011	powchik peter	Officer	Automatic Sell	10,977	54.74 - 55.19
Jul 25, 2011	powchik peter	Officer	Option Execute	25,000	15.64
Jul 25, 2011	powchik peter	Officer	Automatic Sell	14,023	56.26
May 2, 2013	mccorkle douglas s	Officer	Automatic Sell	2,213	241.45 - 247.21
May 1, 2013	mccorkle douglas s	Officer	Option Execute	5,875	52.03
May 1, 2013	mccorkle douglas s	Officer	Automatic Sell	3,662	233.53
Apr 12, 2013	mccorkle douglas s	Officer	Automatic Sell	3,129	205.82 - 214.10
Apr 11, 2013	mccorkle douglas s	Officer	Option Execute	5,875	30.63
Apr 11, 2013	mccorkle douglas s	Officer	Automatic Sell	2,746	204.57
Dec 19, 2012	mccorkle douglas s	Officer	Automatic Sell	1,841	174.52 - 180.75
Showing 321-340 of 639 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.